Vortioxetine versus reuptake inhibitors in adults with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Eduardo Cerchi BarbosaGiovanna Hanike Santos da SilvaÂngelo Eduardo Espíndola SbardelottoDouglas Carneiro BarrosoFernanda Ribeiro de LimaLoyná Euá Flores E PaezSaulo Bernardo LançaArthur Bezerra Cavalcanti PetrucciFelipe Bandeira de Melo GuimarãesAntônio Leandro NascimentoPublished in: Asian journal of psychiatry (2024)
Our study reveals that vortioxetine is as effective as SSRIs and SNRIs for treating MDD, with safety equivalent to SSRIs and superior to SNRIs.